Aspirin was associated with decreased mortality in SIMI patients, and this beneficial effect persisted regardless of pre-ICU treatment.
Keyphrases
- cardiovascular events
- low dose
- end stage renal disease
- intensive care unit
- newly diagnosed
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- antiplatelet therapy
- prognostic factors
- high glucose
- cardiovascular disease
- coronary artery disease
- emergency department
- diabetic rats
- metabolic syndrome
- percutaneous coronary intervention
- adipose tissue
- drug induced
- patient reported outcomes
- combination therapy
- septic shock
- adverse drug